Simulations Plus to Present at the 21st Annual Needham Growth Conference
January 10 2019 - 8:30AM
Business Wire
Simulations Plus, Inc. (Nasdaq:SLP), the premier provider of
simulation and modeling software and consulting services for
pharmaceutical discovery and development, today announced that
chief executive officer Shawn O’Connor will present at the 21st
Annual Needham Growth Conference in New York City on Wednesday,
January 16, 2019, at 8:40 a.m. ET (5:40 a.m. PT). In addition to
his presentation, Mr. O’Connor will host one-on-one meetings
throughout the day at the conference which will be held at the
Lotte New York Palace Hotel.
A live webcast of the presentation will be accessible from the
Events section of the Company's website (www.simulations-plus.com).
The webcast will be archived for a period of 90 days. For more
information about the conference or to schedule a one-on-one
meeting with Mr. O’Connor, please contact Hayden IR at
slp@haydenir.com.
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of drug discovery
and development software as well as a leading provider of both
preclinical and clinical pharmacometric consulting services for
regulatory submissions and quantitative systems pharmacology models
for drug-induced liver injury, drug-induced kidney injury, and
nonalcoholic fatty liver disease. The company is a global leader
focused on improving the ways scientists use knowledge and data to
predict the properties and outcomes of pharmaceutical,
biotechnology, and chemical agents. Our software is licensed to and
used in the conduct of drug research by major pharmaceutical,
biotechnology, chemical, and consumer goods companies and
regulatory agencies worldwide. Our innovations in integrating new
and existing science in medicinal chemistry, computational
chemistry, pharmaceutical science, biology, and physiology into our
software have made us the leading software provider for
physiologically based pharmacokinetic modeling and simulation. For
more information, visit our website at www.simulations-plus.com
Follow us on Twitter | LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190110005182/en/
Simulations Plus Investor
RelationsMs. Renee
Bouche661-723-7723renee@simulations-plus.com
Hayden IRMr. Cameron
Donahue651-653-1854cameron@haydenir.com
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Apr 2023 to Apr 2024